1.Acupuncture-moxibustion for essential hypertension: an overview of systematic reviews
Wanyan CHEN ; Kelin DENG ; Junxuan LEI ; Lin DAI ; Kejian LI ; Yina LUO ; Jingxian XIA ; Rong LIN ; Xiaowen QIANG ; Lianyang XU ; Min LI
Journal of Acupuncture and Tuina Science 2023;21(2):162-172
Objective: To propose reasonable suggestions to promote the standardization of clinical studies by reviewing the systematic reviews and meta-analyses of acupuncture-moxibustion treatment of essential hypertension (EH). Methods: Computer retrieval was conducted through Excerpta Medica Database (EMBASE), PubMed, China National Knowledge Infrastructure (CNKI), Chongqing VIP Database (CQVIP), China Biology Medicine Disc (CBM), and Wanfang Academic Journal Full-text Database (Wanfang) to collect systematic reviews and meta-analyses relevant to treating EH with acupuncture-moxibustion therapy. The time range was from the database's inception till July, 2020. The studies were screened based on the inclusion and exclusion criteria and then data-extracted. The study's quality and evidence ratings were performed by referring to the preferred reporting items for systematic review and meta-analysis (PRISMA), a measurement tool to assess systematic reviews 2 (AMSTAR 2), and the grading of recommendations, assessment, development, and evaluation (GRADE). Results: A total of 14 studies, 10 in Chinese and 4 in English, published between 2012 and 2019, were included, involving 70 outcome measures. The methodological quality was rated as critically low, the reporting was relatively complete or had certain flaws, and the evidence strength was rated as low or very low. Conclusion: Regarding the acupuncture-moxibustion treatment of EH, the methodological quality and outcome measure evidence of existing systematic reviews and meta-analyses are relatively low, and the reporting quality also expects further improvements.
2.Study on Improvement Effect of Methylated Urolithin A on Oleic Acid-induced Lipid Accumulation in Huh- 7 Cells and Its Me- chanism
Cong ZHANG ; Junxuan ZHOU ; Lei SHENG ; Junqiao MA ; Xin LI ; Guohua ZHENG ; Sidan LIU ; Zhengpeng QIU
China Pharmacy 2019;30(6):741-746
OBJECTIVE: To study the improvement effect and mechanism of methylated urolithin A on oleic acid-induced lipid accumulation in human liver cancer Huh-7 cells. METHODS: Oleic acid was adopted to induce lipid accumulation model cells. Huh-7 cells were divided into control group (culture medium), model group (1 mmol/L oleic acid), low-dose group (1 mmol/L oleic acid+10 μmol/L methylated urolithin A) and high-dose group (1 mmol/L oleic acid+20 μmol/L methylated urolithin A). Oil red O staining was used to observe lipid accumulation in cells. Triglyceride(TG) enzyme assay was applied to determine the TG content in cells. PCR was employed to detect the mRNA expression of FASN, SREBP-1, PPAR-α and PPAR-γ in cells. Western blotting was used to determine the protein expression of FASN in cells. RESULTS: After induced by oleic acid, a large amount of lipid droplet accumulated around the cells; the intracellular lipid and TG content, mRNA expression levels of FASN, SREBP-1 and PPAR-γ, protein expression levels of FASN were increased significantly, while mRNA expression level of PPAR-α was decreased significantly (P<0.01). After intervened with methylated urolithin A, lipid droplet around the cells decreased significantly; the contents of lipid and TG in cells were decreased significantly, while the mRNA expression levels of FASN, SREBP-1 and PPARγ and protein expression level of FASN were decreased significantly (P<0.05 or P<0.01). CONCLUSIONS: Methylated urolithin A can improve oleic acid-induced lipid accumulation in Huh-7 cells, the mechanism of which may be associated with inhibiting fat synthesis, promoting lipid metabolism and down-regulating the expression of metabolism-related factors as FASN, SREBP-1 and PPAR-γ.